Basics Arvinas, Inc. IPO Date: September 24, 2018 Sector: Healthcare Industry: Biotech Market Cap: $713.62M Activated in VL: True Average Daily Range Avg Daily Range: $1.06 | 2.93% Avg Daily Range (30 D): $0.19 | 2.19% Avg Daily Range (90 D): $0.17 | 2.16% Institutional Daily Volume Avg Daily Volume: .58M Avg Daily Volume (30 D): 1.97M Avg Daily Volume (90 D): 1.67M Trade Size Avg Trade Size (Sh.): 72 Avg Trade Size (Sh.) (30 D): 105 Avg Trade Size (Sh.) (90 D): 102 Institutional Trades Total Inst.Trades: 3,108 Avg Inst. Trade: $2.2M Avg Inst. Trade (30 D): $2.37M Avg Inst. Trade (90 D): $2.03M Avg Inst. Trade Volume: .07M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.61M Avg Closing Trade (30 D): $2.31M Avg Closing Trade (90 D): $1.97M Avg Closing Volume: 87.38K     News Oct 22, 2025 @ 8:00 PM Arvinas to Present Preclinical Data for ARV-806, a... Source: Arvinas, Inc. Oct 13, 2025 @ 11:00 AM Arvinas to Present Data from the Vepdegestrant Cli... Source: Arvinas, Inc. Oct 5, 2025 @ 6:00 PM Arvinas Presents Late Breaking, Positive Phase 1 C... Source: Arvinas, Inc. Oct 1, 2025 @ 11:00 AM Arvinas to Present Clinical Data for ARV-102, a PR... Source: Arvinas, Inc. Aug 29, 2025 @ 11:00 AM Arvinas to Participate in Upcoming Investor Confer... Source: Arvinas, Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.84 $1.14 Diluted EPS $-.84 $1.14 Revenue $ $ 22.4M $ 188.8M Gross Profit $ $ $ Net Income / Loss $ $ -61.2M $ 82.9M Operating Income / Loss $ $ -71.5M $ 71.4M Cost of Revenue $ $ $ Net Cash Flow $ $ 33.9M $ -19.5M PE Ratio